Hatic E, Färdig M, Amaral AFS, Jarvis D, Accordini S, Bousquet J, Garcia-Aymerich J, Tan WC, Zuberbier T, Janson C, Malinovschi A. ERJ Open Res. 2025 Jun 16;11(3):01162-2024. doi: 10.1183/23120541.01162-2024.
The proposed ERS/ATS 2022 guidelines appear to underestimate the prevalence of spirometry response to bronchodilator and individuals not identified have higher respiratory burden, potentially leading to additional testing and delayed asthma diagnosis.